117 related articles for article (PubMed ID: 23262391)
1. Commentary: dermal penetration of bisphenol A--consequences for risk assessment.
Gundert-Remy U; Mielke H; Bernauer U
Toxicol Lett; 2013 Feb; 217(2):159-61. PubMed ID: 23262391
[TBL] [Abstract][Full Text] [Related]
2. The contribution of dermal exposure to the internal exposure of bisphenol A in man.
Mielke H; Partosch F; Gundert-Remy U
Toxicol Lett; 2011 Jul; 204(2-3):190-8. PubMed ID: 21571050
[TBL] [Abstract][Full Text] [Related]
3. In vitro percutaneous absorption and metabolism of Bisphenol A (BPA) through fresh human skin.
Toner F; Allan G; Dimond SS; Waechter JM; Beyer D
Toxicol In Vitro; 2018 Mar; 47():147-155. PubMed ID: 29154941
[TBL] [Abstract][Full Text] [Related]
4. Extensive metabolism and route-dependent pharmacokinetics of bisphenol A (BPA) in neonatal mice following oral or subcutaneous administration.
Draganov DI; Markham DA; Beyer D; Waechter JM; Dimond SS; Budinsky RA; Shiotsuka RN; Snyder SA; Ehman KD; Hentges SG
Toxicology; 2015 Jul; 333():168-178. PubMed ID: 25929835
[TBL] [Abstract][Full Text] [Related]
5. Human risk assessment of dermal and inhalation exposures to chemicals assessed by route-to-route extrapolation: the necessity of kinetic data.
Geraets L; Bessems JG; Zeilmaker MJ; Bos PM
Regul Toxicol Pharmacol; 2014 Oct; 70(1):54-64. PubMed ID: 24912090
[TBL] [Abstract][Full Text] [Related]
6. Dermal penetration of bisphenol A in human skin contributes marginally to total exposure.
Demierre AL; Peter R; Oberli A; Bourqui-Pittet M
Toxicol Lett; 2012 Sep; 213(3):305-8. PubMed ID: 22796587
[TBL] [Abstract][Full Text] [Related]
7. Case study: Is bisphenol S safer than bisphenol A in thermal papers?
Sogorb MA; Estévez J; Vilanova E
Arch Toxicol; 2019 Jul; 93(7):1835-1852. PubMed ID: 31111188
[TBL] [Abstract][Full Text] [Related]
8. In vivo and ex vivo percutaneous absorption of [14C]-bisphenol A in rats: a possible extrapolation to human absorption?
Marquet F; Payan JP; Beydon D; Wathier L; Grandclaude MC; Ferrari E
Arch Toxicol; 2011 Sep; 85(9):1035-43. PubMed ID: 21287149
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the contribution of buccal absorption to internal exposure to bisphenol A through the diet.
Guignard D; Gauderat G; Gayrard V; Lacroix MZ; Picard-Hagen N; Puel S; Toutain PL; Viguié C
Food Chem Toxicol; 2016 Jul; 93():82-8. PubMed ID: 27090580
[TBL] [Abstract][Full Text] [Related]
10. Physiologically based toxicokinetic modelling as a tool to assess target organ toxicity in route-to-route extrapolation--the case of coumarin.
Mielke H; Abraham K; Götz M; Vieth B; Lampen A; Luch A; Gundert-Remy U
Toxicol Lett; 2011 Apr; 202(2):100-10. PubMed ID: 21291965
[TBL] [Abstract][Full Text] [Related]
11. Application of physiologically-based toxicokinetic modelling in oral-to-dermal extrapolation of threshold doses of cosmetic ingredients.
Gajewska M; Worth A; Urani C; Briesen H; Schramm KW
Toxicol Lett; 2014 Jun; 227(3):189-202. PubMed ID: 24731971
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic modeling: prediction and evaluation of route dependent dosimetry of bisphenol A in monkeys with extrapolation to humans.
Fisher JW; Twaddle NC; Vanlandingham M; Doerge DR
Toxicol Appl Pharmacol; 2011 Nov; 257(1):122-36. PubMed ID: 21920375
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: a physiologically based pharmacokinetic approach.
Teeguarden JG; Waechter JM; Clewell HJ; Covington TR; Barton HA
Toxicol Sci; 2005 Jun; 85(2):823-38. PubMed ID: 15746009
[TBL] [Abstract][Full Text] [Related]
14. Steady-state solutions to PBPK models and their applications to risk assessment I: Route-to-route extrapolation of volatile chemicals.
Chiu WA; White P
Risk Anal; 2006 Jun; 26(3):769-80. PubMed ID: 16834633
[TBL] [Abstract][Full Text] [Related]
15. The margin of internal exposure (MOIE) concept for dermal risk assessment based on oral toxicity data - A case study with caffeine.
Bessems JGM; Paini A; Gajewska M; Worth A
Toxicology; 2017 Dec; 392():119-129. PubMed ID: 28288858
[TBL] [Abstract][Full Text] [Related]
16. Physiologically based modelling of dermal absorption and kinetics of consumer-relevant chemicals: A case study with exposure to bisphenol A from thermal paper.
Wiśniowska B; Linke S; Polak S; Bielecka Z; Luch A; Pirow R
Toxicol Appl Pharmacol; 2023 Jan; 459():116357. PubMed ID: 36572228
[TBL] [Abstract][Full Text] [Related]
17. High bioavailability of bisphenol A from sublingual exposure.
Gayrard V; Lacroix MZ; Collet SH; Viguié C; Bousquet-Melou A; Toutain PL; Picard-Hagen N
Environ Health Perspect; 2013 Aug; 121(8):951-6. PubMed ID: 23761051
[TBL] [Abstract][Full Text] [Related]
18. Development of a physiologically based pharmacokinetic model for bisphenol A in pregnant mice.
Kawamoto Y; Matsuyama W; Wada M; Hishikawa J; Chan MP; Nakayama A; Morisawa S
Toxicol Appl Pharmacol; 2007 Oct; 224(2):182-91. PubMed ID: 17698157
[TBL] [Abstract][Full Text] [Related]
19. Including non-dietary sources into an exposure assessment of the European Food Safety Authority: The challenge of multi-sector chemicals such as Bisphenol A.
von Goetz N; Pirow R; Hart A; Bradley E; Poças F; Arcella D; Lillegard ITL; Simoneau C; van Engelen J; Husoy T; Theobald A; Leclercq C
Regul Toxicol Pharmacol; 2017 Apr; 85():70-78. PubMed ID: 28185845
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of in-vivo animal and in-vitro models for prediction of dermal absorption in man.
Jakasa I; Kezic S
Hum Exp Toxicol; 2008 Apr; 27(4):281-8. PubMed ID: 18684798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
